Abstract Background: Heart failure (HF) after acute myocardial infarction (AMI) remains a major cause of morbidity and mortality despite advances in conventional therapy. Qili Qiangxin Capsule (QLQX) has been widely used as an adjunctive treatment for HF in China, but its efficacy and safety in patients with HF after AMI require further evaluation. Methods: Seven databases were searched from their inception to January 2026.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jun-Hong
Contact Jun-Hong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack